Research Library

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.

Two new bills introduced in the Texas Legislature could jeopardize the care received by Medicaid patients, writes Vivian Ho, the James A. Baker III Institute Chair in Health Economics. She explains why the legislation would weaken county-owned insurance plans and raise Texans’ tax bills.

Texas lawmakers must address the misuse of anticipation notes — short-term debt securities used to raise money for public projects, writes John Diamond, the Edward A. and Hermena Hancock Kelly Fellow in Public Finance. Since they don’t require voter approval, politicians could use them to fund unwanted projects, he explains.

Energy experts suggest a few market design remedies to improve weatherization incentives following the deadly Texas freeze in 2021.

Ten months after the pandemic began, partisan division is severely inhibiting the United States’ COVID-19 response. The health consequences of the continued political divide could not be clearer, as the pandemic has grown beyond many experts’ worst predictions.

In late July, Texas Comptroller Glenn Hegar delivered a bleak economic outlook for the state’s economy: the amount of general revenue funds available for the current biennium is expected to be $11.5 billion less than originally estimated. Should the state tap into its rainy day fund to offset the impact of the coronavirus pandemic and facilitate a stable recovery?

Despite the wealth of evidence attesting to the efficacy of medication-assisted treatment for opioid addiction, the majority of Americans who need it can't get it — including in Harris County, Texas’ largest county. Baker Institute Blog: https://bit.ly/31D9qGV